Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesFDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
Amgen, 02/19/09
Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted Amgen's submission and filed a Biologics License Application (BLA) for denosumab, an investigational RANK Ligand inhibitor. The indications for which Amgen is seeking FDA approval are treatment and prevention of postmenopausal osteoporosis (PMO) in women and treatment and prevention of bone loss in patients undergoing hormone ablation therapy for either prostate or breast cancer.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
Office Alley Gets EHNAC Accreditation
HealthDataManagement, 11/25/09
The Joint Commission Introduces Perinatal Care Core Measures
Joint Commission news, 11/24/09
Development of a Portable Linux-Based ECG Measurement and Monitoring System
The Journal of Medical Systems, 11/18/09
Article Search
Sponsor